No. of residents (%) | P value | ||
---|---|---|---|
Baseline Characteristics | ESBL-E carriers (n = 10) | Non carriers (n = 134) | |
Sex (females) | 7 (70) | 90 (67) | 0.8 |
Age, mean (SD) | 85.6 (±5.82) | 86.13 (±6.61) | 0.53 |
Dementia | 7 (70) | 78 (58) | 0.48 |
Parkinson disease | 0 (0) | 9 (7) | 0.4 |
Diabete | 0 (0) | 30 (22) | 0.095 |
Peptic ulcer disease | 1 (10) | 13 (10) | 0.98 |
Chronical kidney disease | 1 (10) | 14 (10) | 0.96 |
Long term stay (> 24 months) | 5 (50) | 94 (70) | 0.188 |
Medications during past 3 months | |||
Oral antidiabetic medication | 1 (10) | 10 (7) | 0.78 |
Anti-acid medication | 4 (40) | 26 (19) | 0.124 |
Broad spectum pennicilin | 4 (40) | 41 (31) | 0.54 |
Anxiolytic medication | 7 (70) | 98 (73) | 0.82 |
Antidepressant medication | 3 (30) | 75 (56) | 0.11 |
Antiepileptic medication | 1 (10 | 24 (18) | 0.53 |
Proton-pump inhibitors | 1 (10) | 5 (4) | 0.35 |